Trending Stock News

Archford Capital Strategies Boosted Astrazeneca Plc Sponsored Adr (AZN) Position by $1.60 Million; Valuation Rose; Arete Wealth Advisors Has Lowered Its Holding in Marathon Pete (MPC) as Market Value Rose

AstraZeneca PLC (NYSE:AZN) Logo

Arete Wealth Advisors Llc decreased its stake in Marathon Pete Corp (MPC) by 72.02% based on its latest 2018Q1 regulatory filing with the SEC. Arete Wealth Advisors Llc sold 7,148 shares as the company’s stock rose 16.16% while stock markets declined. The institutional investor held 2,777 shares of the integrated oil company at the end of 2018Q1, valued at $203,000, down from 9,925 at the end of the previous reported quarter. Arete Wealth Advisors Llc who had been investing in Marathon Pete Corp for a number of months, seems to be less bullish one the $34.14 billion market cap company. The stock decreased 0.81% or $0.6027 during the last trading session, reaching $73.9173. About 1.96 million shares traded. Marathon Petroleum Corporation (NYSE:MPC) has risen 46.81% since June 20, 2017 and is uptrending. It has outperformed by 34.24% the S&P500. Some Historical MPC News: 17/05/2018 – DGAP-NEWS: MPC CAPITAL AG: KEY FIGURES FOR THE 1ST QUARTER 2018; 22/05/2018 – NIGERIA MPC SEES UPWARD PRICE PRESSURE FROM LATE BUDGET PASSAGE; 24/05/2018 – S. AFRICA’S KGANYAGO: MPC WILL LOOK THROUGH 1ST ROUND EFFECTS; 06/03/2018 MARATHON GALVESTON BAY TEXAS REFINERY PLANS TO RESTART REFORMER BY EARLY NEXT WEEK; 24/05/2018 – SOUTH AFRICA’S RAND ZAR=D3 STEADY AT 12.41 AGAINST DOLLAR AFTER CENTRAL BANK GOVERNOR BEGINS READING MPC STATEMENT; 08/05/2018 – MARATHON, VALERO REFINERIES IN TEXAS CITY, TEXAS, LOSE POWER DUE TO SUBSTATION FIRE; 18/04/2018 – POLISH MPC MAY FOCUS ON SUPPORTING GDP GROWTH SINCE CPI IS NOT AN ISSUE – MPC MEMBER KROPIWNICKI; 30/04/2018 – Dawn Kopecki: BREAKING: Marathon Petroleum to buy San Antonio-based Andeavor in $23.3 billion deal; 30/04/2018 – Correct: Marathon Petroleum 1Q Rev $18.98B; 12/03/2018 – Marathon Galveston Bay Refinery preparing to shut alky unit

Archford Capital Strategies Llc increased its stake in Astrazeneca Plc Sponsored Adr (AZN) by 175.22% based on its latest 2018Q1 regulatory filing with the SEC. Archford Capital Strategies Llc bought 46,976 shares as the company’s stock rose 8.34% while stock markets declined. The institutional investor held 73,786 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $2.56 million, up from 26,810 at the end of the previous reported quarter. Archford Capital Strategies Llc who had been investing in Astrazeneca Plc Sponsored Adr for a number of months, seems to be bullish on the $90.78 billion market cap company. The stock increased 0.18% or $0.07 during the last trading session, reaching $36.01. About 1.27M shares traded. AstraZeneca PLC (NYSE:AZN) has risen 7.86% since June 20, 2017 and is uptrending. It has underperformed by 4.71% the S&P500. Some Historical AZN News: 03/04/2018 – US FDA ACCEPTS BIOLOGICS LICENSE APPLICATION FOR MOXETUMOMAB PA; 19/03/2018 – AstraZeneca Presents New Data Evaluating Safety and Efficacy of FARXIGA in Patients with Type 2 Diabetes and Moderate Renal Impairment; 07/05/2018 – LUYE PHARMA GROUP – ASTRAZENECA TO TRANSFER ASSETS & GRANT A LICENCE FOR ASSETS TO UNIT IN TERRITORIES INCLUDING CHINA, BRAZIL, AMONG OTHERS; 08/05/2018 – ASTRAZENECA PLC AZN.L – TO RECEIVE UPFRONT PAYMENT AND FUTURE PAYMENTS; 30/05/2018 – AstraZeneca’s Second Fasenra Phase 3 Trial Doesn’t Meet Primary Endpoint; 25/05/2018 – IMFINZI® (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non; 03/04/2018 – The European Medicines Agency Accepts Regulatory Submission for LYNPARZA® (olaparib) in BRCA-Mutated HER2-Negative Metastatic; 12/03/2018 – Two PARPi + PD-(L)1 combo data sets in ovarian cancer to be presented as late breaks at #SGO2018 $AZN olaparib + durvalumab in gBRCAm platinum-sensitive relapsed OC $TSRO niraparib + pembrolizumab in platinum-resistant OC; 16/03/2018 – GERMANY’S GBA SEES NO ADDED BENEFIT FOR NOVARTIS’S KISQALI; 10/04/2018 – NOVARTIS AG NOVN.S – AFINITOR DISPERZ RECEIVES FDA APPROVAL TO TREAT TSC-ASSOCIATED PARTIAL-ONSET SEIZURES

Among 21 analysts covering Marathon Petroleum Corp (NYSE:MPC), 17 have Buy rating, 0 Sell and 4 Hold. Therefore 81% are positive. Marathon Petroleum Corp had 93 analyst reports since August 10, 2015 according to SRatingsIntel. On Thursday, July 20 the stock rating was maintained by RBC Capital Markets with “Buy”. Bank of America upgraded Marathon Petroleum Corporation (NYSE:MPC) on Tuesday, January 5 to “Neutral” rating. The stock of Marathon Petroleum Corporation (NYSE:MPC) has “Buy” rating given on Friday, December 4 by Deutsche Bank. The stock of Marathon Petroleum Corporation (NYSE:MPC) has “Hold” rating given on Friday, May 18 by Tudor Pickering. Barclays Capital maintained Marathon Petroleum Corporation (NYSE:MPC) on Wednesday, March 16 with “Overweight” rating. The stock of Marathon Petroleum Corporation (NYSE:MPC) earned “Overweight” rating by JP Morgan on Wednesday, August 26. As per Friday, August 25, the company rating was maintained by Jefferies. The stock of Marathon Petroleum Corporation (NYSE:MPC) earned “Overweight” rating by Barclays Capital on Tuesday, January 12. RBC Capital Markets maintained Marathon Petroleum Corporation (NYSE:MPC) rating on Tuesday, January 30. RBC Capital Markets has “Buy” rating and $89.0 target. Piper Jaffray maintained it with “Neutral” rating and $41 target in Monday, August 22 report.

Analysts await Marathon Petroleum Corporation (NYSE:MPC) to report earnings on July, 26. They expect $1.71 EPS, up 66.02% or $0.68 from last year’s $1.03 per share. MPC’s profit will be $789.82 million for 10.81 P/E if the $1.71 EPS becomes a reality. After $0.08 actual EPS reported by Marathon Petroleum Corporation for the previous quarter, Wall Street now forecasts 2,037.50% EPS growth.

More recent Marathon Petroleum Corporation (NYSE:MPC) news were published by: Bizjournals.com which released: “Behind The Deal: Andeavor looked to be bought while closing Western Refining acquisition” on June 04, 2018. Also Seekingalpha.com published the news titled: “Reuters: Marathon Petroleum seeking EPA biofuel waiver” on May 23, 2018. 247Wallst.com‘s news article titled: “5 Stocks to Buy Now If You Fear a Trade War Market Crash” with publication date: June 20, 2018 was also an interesting one.

Arete Wealth Advisors Llc, which manages about $501.94 million and $301.53 million US Long portfolio, upped its stake in Dreyfus Strategic Mun Bd Fd (DSM) by 73,301 shares to 395,961 shares, valued at $3.01M in 2018Q1, according to the filing. It also increased its holding in Pimco Etf Tr (HYS) by 3,084 shares in the quarter, for a total of 31,395 shares, and has risen its stake in New York Cmnty Cap Tr V.

Since March 6, 2018, it had 1 buying transaction, and 2 insider sales for $3.27 million activity. $101,070 worth of Marathon Petroleum Corporation (NYSE:MPC) was bought by BUNCH CHARLES E on Tuesday, March 6.

Investors sentiment decreased to 0.9 in 2018 Q1. Its down 0.06, from 0.96 in 2017Q4. It worsened, as 52 investors sold MPC shares while 322 reduced holdings. 98 funds opened positions while 239 raised stakes. 354.13 million shares or 3.74% less from 367.91 million shares in 2017Q4 were reported. Contravisory has invested 0.01% in Marathon Petroleum Corporation (NYSE:MPC). Pittenger And Anderson Inc accumulated 0.36% or 56,830 shares. Tarbox Family Office owns 2,447 shares or 0.07% of their US portfolio. Alps Advsrs Incorporated reported 6,944 shares. Lloyds Banking Gp Public Ltd invested in 0.21% or 378 shares. Banced stated it has 0.99% of its portfolio in Marathon Petroleum Corporation (NYSE:MPC). Chicago Equity Prtnrs Ltd Liability Co owns 12,025 shares or 0.03% of their US portfolio. Stratos Wealth reported 12,014 shares. 240,672 were accumulated by Ontario Teachers Pension Plan Board. First Manhattan has invested 0.01% in Marathon Petroleum Corporation (NYSE:MPC). Amalgamated National Bank & Trust reported 0.12% of its portfolio in Marathon Petroleum Corporation (NYSE:MPC). Fdx Advsr Incorporated holds 0.04% in Marathon Petroleum Corporation (NYSE:MPC) or 18,661 shares. Cadence Retail Bank Na reported 9,574 shares. Nomura Asset Mngmt Limited accumulated 87,312 shares. Martingale Asset Mngmt Ltd Partnership invested in 0.1% or 102,326 shares.

More notable recent AstraZeneca PLC (NYSE:AZN) news were published by: Bizjournals.com which released: “Why Big Pharma is finally discovering the Bay Area” on May 23, 2018, also Seekingalpha.com with their article: “Breaking Down Barriers: BiOasis Technologies Promises Breakthrough Brain Drug Delivery” published on June 19, 2018, Seekingalpha.com published: “Avoiding The ‘Black Hole’ Of Disease Development” on June 15, 2018. More interesting news about AstraZeneca PLC (NYSE:AZN) were released by: Seekingalpha.com and their article: “Alzheimer’s Disease: A History Of Drug Failures” published on June 19, 2018 as well as Seekingalpha.com‘s news article titled: “Lilly and AstraZeneca bail on AD candidate lanabecestat” with publication date: June 12, 2018.

Archford Capital Strategies Llc, which manages about $349.45 million and $239.94 million US Long portfolio, decreased its stake in Humana Inc Com (NYSE:HUM) by 3,352 shares to 17 shares, valued at $4,000 in 2018Q1, according to the filing.

Marathon Petroleum Corporation (NYSE:MPC) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *